The Full Text of this article is available as a PDF (96K).
These references are in PubMed. This may not be the complete list of references from this article.
Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 1998 Jul 11;352(9122):98–101.[PubMed]
Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801.[PubMed]
Emery S, Gilpin EA, White MM, Pierce JP. How adolescents get their cigarettes: implications for policies on access and price. J Natl Cancer Inst. 1999 Jan 20;91(2):184–186.[PubMed]
Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res. 1996 Feb 1;56(3):556–562.[PubMed]
Shalet SM. Radiation and pituitary dysfunction. N Engl J Med. 1993 Jan 14;328(2):131–133.[PubMed]
Smigel K. Arthritis drug approved for polyp prevention blazes trail for other prevention trials. J Natl Cancer Inst. 2000 Feb 16;92(4):297–299.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press